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A
 
BSTRACT
Background:
 
Colonization of atopic dermatitis lesions
with 
 
Staphylococcus aureus
 
 is a frequent phenomenon
and may exacerbate inflammation of the skin. The
aim of the present study was to determine the effect
of  
 
S. aureus
 
 on T cell-mediated immune responses in
contact hypersensitivity caused by a hapten or a
protein with large molecule.
 
Methods:
 
Staphylococcus aureus
 
 or phosphate-buffered
saline was inoculated on experimental contact derma-
titis induced by 2,4,6-trinitro-1-chlorobenzene (TNCB)
or house dust mite antigen. At various times after
inoculation, the experimental lesions were examined
histologically and immunohistochemically. Furthermore,
the kinetics of cytokine patterns (interferon (IFN)-
 
γ
 
,
interleukin (IL)-2, IL-4 and IL-5) in each lesion were
analyzed by reverse transcription–polymerase chain
reaction.
 
Results:
 
In TNCB-challenged lesions inoculated with
 
S. aureus
 
, the levels of IL-2 mRNA decreased; in con-
trast, mRNA levels of IL-4 and IL-5 were upregulated.
In mite antigen-challenged lesions, IL-4 and IL-5
mRNA expression was detected throughout the period
of the investigation, even without 
 
S. aureus
 
 inoculation.
Interferon-
 
γ
 
 mRNA expression in mite dermatitis
without 
 
S. aureus
 
 inoculation was observed only in the
later period and IL-2 mRNA expression in mite derma-
titis with 
 
S. aureus
 
 was suppressed and observed much
later than in the control group.
 
Conclusions:
 
Infestation of 
 
S. aureus
 
 on skin lesions
in experimental contact hypersensitivity induces a shift
in the immune reaction from a Th1- to a Th2-dominant
response.
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I
 
NTRODUCTION
 
Atopic dermatitis (AD) is a chronic and relapsing inflam-
matory skin disease characterized by increased IgE
production and positive hypersensitivity to environmental
allergens. Acute AD lesions are characterized by the
presence of T cells producing classical type 2 cytokines,
including interleukin (IL)-4 and IL-5.
 
1,2
 
 T Cell activation is
associated with an imbalance in cytokine production
resulting in an increased production of IL-4 and a
reduction of interferon (IFN)-
 
γ
 
,
 
3
 
 although in the chronic
phase of AD lesions the production of type 1 cytokines,
such as IFN-
 
γ
 
, increases.
 
4
 
 
 
Staphylococcus aureus
 
 can be
isolated from skin lesions in approximately 95% of all
AD patients, but only in approximately 5% of non-atopic
patients.
 
5
 
 The presence of 
 
S. aureus
 
 on inflamed AD
lesions without clinical superinfections can reach
10
 
6
 
 colony forming units (c.f.u.)/cm
 
2
 
,
 
6
 
 and can cause
severe exacerbation of the disease in many patients,
although it is often responsive to antistaphylococcal
therapy.
 
5,7
 
The underlying mechanisms of this chronic bacterial
colonization of the skin and the roles of 
 
S. aureus
 
 in aller-
gic reactions in AD are unclear. To define the roles of
 
S. aureus
 
 in AD, we examined the effect of inoculation
with 
 
S. aureus
 
 on experimental contact dermatitis lesions
developed with a hapten (2,4,6-trinitro-1-chlorobenzene;
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TNCB) or an aeroallergen (house dust mite antigen;
 
Dermatophagoides farinae
 
). Because hapten-induced
contact dermatitis is considered to be a classic Th1-type
immune response in the skin
 
8
 
 and contact hypersensitivity
induced by a high molecular weight protein, such as mite
antigen, shows a Th2-type reaction,
 
9
 
 in the present
experimental model we are able to observe the effects
of  
 
S. aureus
 
 on the two Th1- and Th2-type immune
reactions, instead of original AD lesions showing compli-
cated cytokine profiles.
 
4
 
M
 
ETHODS
 
Bacteria
 
We used an 
 
S. aureus
 
 strain isolated from a patient
with atopic dermatitis to produce staphylococcal entero-
toxin B (SEB). The 
 
S. aureus
 
 was grown overnight in
Brain–Heart–Infusion broth (Nissui Pharmaceutical,
Tokyo, Japan) at 37
 
°
 
C with shaking. The 
 
S. aureus
 
 was
washed in sterile phosphate-buffered saline (PBS) and
the 
 
S. aureus
 
 cells were resuspended in PBS. The cell
suspension was then divided into individual inoculum
sizes of 10
 
6
 
 colony forming units (c.f.u.)/mL.
 
Sensitization and elicitation procedure
 
Female BALB/c mice were obtained from the Mouse
Colony of Okayama University Medical School and
were used at the age of 5–6 weeks.
House dust mite antigen (Df), 
 
Dermatophagoides
farinae
 
 body extract, was obtained from Torii Pharma-
ceutical (Tokyo, Japan). We dissolved TNCB (Tokyo
Kasei, Tokyo, Japan) in a solvent (acetone and olive oil
1 : 4) and used a 0.5% solution for sensitization and a
0.005% solution for elicitation. The Df antigen dissolved
in PBS at 5 mg/mL was prepared for sensitization and 1%
Df antigen in white petrolatum containing 0.1% sodium
dodecyl sulfate (SDS) was prepared for elicitation.
Mice were barrier disrupted by repeated applications
and detachments of adhesive cellophane tape on shaved
abdominal skin. Percutaneous sensitization with the anti-
gens was performed by topical application of 20 
 
µ
 
L of
0.1% TNCB or 50 
 
µ
 
L Df (5 mg/mL in PBS) onto the
barrier-disrupted abdominal skin. Seven days after sensi-
tization, 10 
 
µ
 
L of 0.005% TNCB (TNCB contact derma-
titis) or 0.1 g of 1% Df ointment (Df contact dermatitis)
was applied to the shaved dorsal skin of the mice.
 
Inoculation on mice
 
The 
 
S. aureus
 
 cells were inoculated on the skin accord-
ing to the method of Abe 
 
et al
 
.
 
10
 
 Briefly, 12 h after
elicitation, 50 
 
µ
 
L of each of the bacterial suspensions
was applied onto the back skin lesions of the mice. The
inoculated sites were occluded with sterile plastic film
followed by a tight dressing with vinyl adhesive tape. As
a control, PBS was applied instead of 
 
S. aureus
 
 suspen-
sions in some cases.
 
Histologic examinations
 
Biopsy specimens were taken at 0, 6, 12, 18 and 60 h
after inoculation of the bacterial suspension. Half the
specimens were fixed in 10% formalin solution and
embedded in paraffin, whereas the other half were snap-
frozen in liquid nitrogen and stored at –70
 
°
 
C until use.
Paraffin sections were stained using hematoxylin and
eosin.
To confirm IL-4 and IFN-
 
γ
 
 expression in the lesions,
frozen sections (5 
 
µ
 
m) were prepared with a cryostat and
stained by immunofluorescence using fluorescein isothio-
cyanate (FITC)-conjugated anti-IL-4 monoclonal anti-
body (mAb) and rhodamine-conjugated anti-IFN-
 
γ
 
 mAb
(PharMingen, San Diego, CA, USA).
 
Count of viable bacteria in lesions
 
Circular biopsy specimens (1.5 cm in diameter) were
taken from the experimental lesions at 6, 12, 18, 36
and 60 h after inoculation with 
 
S. aureus
 
. Specimens
were minced with a pair of surgical scissors and homog-
enized in 1 mL sterile PBS. A sample of the homogenized
tissue was added to 9 mL sterile PBS and 0.1 mL of this
mixture was cultured on staphylococcal medium no. 110
‘Nissui’ (Nissui Pharmaceutical) using the 10-fold dilu-
tion method. After 48 h incubation at 37
 
°
 
C, the number
of colonies was counted and the c.f.u. measurement was
made.
 
RNA extraction and reverse transcription
 
Biopsy specimens were taken from dorsal skin at various
times after inoculation with 
 
S. aureus
 
. Samples were
homogenized in a solution containing phenol and gua-
nidium isothiocyanate (TRIzol™ Reagent; Life Tech-
nologies, Gaitherburg, MD, USA). After the addition of
chloroform, the solution was mixed and centrifuged.
Then, the aqueous phase was removed and RNA was
precipitated with ethanol. Reverse transcription was
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accomplished with Ready-to-go™ You prime First-Strand
Beads (Pharmacia Biotech, Grand Island, NY, USA),
according to the manufacturer’s instructions. Briefly,
total RNA (5 
 
µ
 
g) from each sample was incubated with
1 U DNase (Gibco, Grand Island, NY, USA) and was
used as a template. This was transferred to each tube in
reaction mix beads and 0.5 
 
µ
 
g oligo dT primer was
added. Reverse transcription was performed at 37
 
°
 
C for
60 min in a total volume of 33 
 
µ
 
L.
 
Polymerase chain reaction
 
Polymerase chain reaction (PCR) was performed using a
thermal cycler (MJ Research, Watertown, MS, USA). The
cDNA was amplified in a 25 
 
µ
 
L reaction volume con-
taining 10 mmol/L Tris-HCl, 50 mmol/L KCl, 1.5 mmol/L
MgCl
 
2
 
, 0.2 mmol/L (each) dNTPs, 0.4 mmol/L primers
and 0.2 U Taq polymerase (Gibco) overlaid with
mineral oil. The PCR primers for IL-2, IL-4, IL-5, IFN-
 
γ
 
and glyceraldehyde-3-phosphate dehydrogenase
(G3PDH) were purchased from Clontech Laboratories
(Palo Alto, CA, USA). Cycle conditions were 94
 
°
 
C for
30 s, 58
 
°
 
C for 30 s and 72
 
°
 
C for 1 min and 30 s. This
process was repeated for 28 cycles with G3PDH primer
and for 33 cycles with IL-2, IL-4, IL-5 and IFN-
 
γ
 
 primers.
After the final cycle, the temperature was maintained at
72
 
°
 
C for 6 min. The PCR products were electrophoresed
through 2% agarose gels in Tris–acetate–EDTA (TAE)
buffer. After staining with ethidium bromide, gels were
photographed under ultraviolet light. Both positive and
negative controls were included in each assay to confirm
that only cDNA PCR was detected and that none of the
reagents was contaminated.
The PCR products were quantitated by analyzing
Polaroid negatives using National Institutes of Health
image (v1.61; Wayne Rasbaund, US National Institutes
of Health, Bethesda, MD, USA) and the results integrated
and normalized to the value of G3PDH. In semiquantita-
tive experiments, the PCR was set up as described above
and the amplifications were run for 24 cycles with
G3PDH primers and for 30 cycles with IL-4 and IFN-
 
γ
 
primers. In the initial experiments, we established stand-
ard curves for G3PDH and these cytokines by titration of
cDNA samples prepared from samples that had the
highest signals for G3PDH and these cytokines. The cycle
numbers were selected because they represented mid-
points of their respective linear ranges for amplification of
cDNA (1 
 
µ
 
L) and because there was a linear correlation
between the input cDNA and the yields of PCR products.
Quantities of cDNA were normalized to yield equivalent
amounts of PCR products for G3PDH and they were
compared with the positive controls.
 
R
 
ESULTS
 
Number of viable bacteria in lesions
 
After inoculation with 
 
S. aureus
 
, the mean values of
viable bacteria on the surface per 1 cm
 
2
 
 were plotted
and are shown in Fig. 1. The bacterial counts were
maintained at 10
 
3
 
–10
 
4
 
 c.f.u./cm
 
2
 
 over time in both the
TNCB and Df contact dermatitis groups.
 
Histological findings
 
At the time of inoculation (12 h after elicitation), the
dermis in both groups showed a similar perivascular
lymphocytic infiltration with scattered eosinophils. The
epidermis also showed signs of spongiosis. After inocu-
lation with 
 
S. aureus
 
, the dermis showed a marked
lymphocytic infiltrate with neutrophils and eosinophils
(Fig. 2a).
Immunohistochemical analysis was also performed
with anti-IL-4 mAb and anti-IFN-
 
γ
 
 mAb using frozen sec-
tions of the TNCB contact dermatitis with 
 
S. aureus
 
, when
increased expression of IL-4 mRNA was detected (see
below). The IL-4 immunoreactivity was localized to small
mononuclear cells in the lower dermis and partly in the
subcutaneous tissue (Fig. 2b). The distribution of IFN-γ
Fig. 1 Number of viable bacteria in contact dermatitis lesions
at various time points after inoculation with Staphylococcus
aureus. The bacterial counts are maintained at 103–104 c.f.u./
cm2 over time in both the 2,4,6-trinitro-1-chlorobenzene
() and Df () contact dermatitis groups.
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was similar to that of IL-4, but not always consistent with
that of IL-4 (Fig. 2c). In contrast, no immunoreactivity for
IL-4 was detected in the TNCB controls (Fig. 2d).
Kinetics of cytokine mRNA expression
As shown in Fig. 3, different patterns of cytokine gene
expression were apparent when comparing the time-
course in the TNCB and Df contact dermatitis groups.
Of the four cytokines tested, the mRNA level for IL-2
and  IFN-γ was higher in the TNCB control group. The
expression of IL-2 mRNA was detected throughout the
investigation period in both control groups, although in
the control group for Df dermatitis mRNA expression for
IFN-γ was markedly suppressed early after inoculation.
The mRNA for the Th2 cytokines IL-4 and IL-5 was not
expressed in the TNCB contact dermatitis control group.
However, the expression of the cytokines was markedly
upregulated in the TNCB contact dermatitis with
S. aureus group. In contrast, the expression of mRNA
for IL-4 and IL-5 was clearly detected in the Df control
group and was moderately enhanced in the Df contact
dermatitis with S. aureus group. Among the four contact
dermatitis groups, the TNCB control group showed a
distinctly suppressed pattern of mRNA expression for
IL-4 and IL-5 compared with the other groups.
The PCR products were applied to the analysis of IL-4
and IFN-γ mRNA expression (Fig. 4) in order to better
quantify the comparisons. In TNCB control lesions, the
production of IFN-γ mRNA was increased from the time
of inoculation (12 h after elicitation) and reached a peak
at 12 h. In the TNCB contact dermatitis with S. aureus
lesions, the levels of IFN-γ mRNA decreased at 6–12 h
without reaching the peak levels observed in the TNCB
control lesions. Interleukin-4 mRNA was never detected
in TNCB control lesions. In contrast, the levels of IL-4
mRNA in the TNCB contact dermatitis with S. aureus
Fig. 2 Light micrographs showing histopathological (a) and
immunohistochemical findings for interleukin (IL)-4 (b) and inter-
feron (IFN)-γ (c) expression in 2,4,6-trinitro-1-chlorobenzene
(TNCB) contact dermatitis 12 h after inoculation with Staphylo-
coccus aureus (24 h after elicitation with TNCB). (a) The TNCB
contact dermatitis with S. aureus is showing a marked lympho-
cytic infiltrate with neutrophils and eosinophils in the dermis.
The overlying epidermis shows some spongiotic changes
(hematoxilin–eosin). (b) The IL-4+ cells are clearly detectable in
the deep dermis and partly in the subcutaneous tissues of TNCB
contact dermatitis with S. aureus 12 h after inoculation. (c) The
distribution of IFN-γ in TNCB contact dermatitis with S. aureus
12 h after inoculation is similar to that of IL-4, although it is not
always consistent with that of IL-4. (d) No immunoreactivity is
present in the TNCB control.
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lesions were upregulated 6 h after inoculation and this
persisted throughout the investigation period. In Df
control lesions, production of IL-4 mRNA gradually
increased from just after the time of inoculation and per-
sisted for 60 h. In the Df with S. aureus lesions, IL-4
mRNA was upregulated and reached a peak at 12 h,
where it remained for 60 h. The expression of IFN-γ
mRNA in Df control lesions was first detected at 24 h,
whereas that in the Df with S. aureus lesions was first
detected at 60 h, although the expression was very low in
comparison with the IL-4 mRNA level. These findings
from PCR analysis indicate that patterns of cytokine
expression in contact hypersensitivity induced by TNCB
shift from a Th1- to a Th2-type cytokine profile in the
presence of S. aureus.
DISCUSSION
In experimental contact hypersensitivity by application of
haptens, CD4+ T cells, especially Th1 cells producing
cytokines such as IL-2 and IFN-γ, play an important role
in the pathophysiological mechanism8 of this condition.
However, although some haptens tend to induce Th1
cells in skin lesions of contact hypersensitivity, others
tend to induce Th2 cells. Kitagaki et al. reported that
Th1 cells predominantly infiltrated in the acute elicitation
phase in mouse contact sensitivity induced by TNCB,
although, in the chronic lesions after repeated applica-
tions of the same hapten, Th2 cells became inversely
more predominant.11 Asada et al. also demonstrated
that Th2 cells expressing mRNA for IL-4 appeared late in
Fig. 3 Reverse transcription–
polymerase chain reaction analy-
sis of the kinetics of cytokine
mRNA expression at various
time points in the 2,4,6-trinitro-
1-chlorobenzene (TNCB) and Df
contact dermatitis groups with or
without Staphylococcus aureus
inoculation. The TNCB control
group (a) shows a distinctly
suppressed pattern in mRNA
expression for the Th2 cytokines
compared with the other groups.
However, the expression of these
cytokines is heavily upregulated
in the TNCB contact dermatitis
with S. aureus group (b). IL,
interleukin; IFN-γ, interferon-γ;
G3PDH, glyceraldehyde-3-phos-
phate dehydrogenase.
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the elicitation phase of contact sensitivity developed by
TNCB, but not during the sensitization phase, and
proposed that the hapten TNCB induced Th2 cells in the
developing stage of contact dermatitis.12 Furthermore,
when contact sensitivity is induced by some haptens in
BALB/c mice, a predominant infiltration of Th2 cells is
seen compared with other mouse strains.13 In the present
study, we demonstrated that regular contact dermatitis
due to the hapten TNCB, showing a Th1 cytokine
pattern, can change following inoculation with S. aureus
to the Th2 pattern.
Dermatophagoides-derived antigens, which have a
much greater molecular weight than TNCB, usually induce
different immune reactions than those induced by con-
ventional haptens. Comoy et al. showed that protease
activity in Dermatophagoides pteronyssinus 1 antigen
played an important role in deviating the immune
response.9 The results of the study of Comoy et al.,9 com-
bined with the present findings, indicate that infestation of
S. aureus on skin lesions in mite antigen-induced experi-
mental contact sensitivity showing a Th2 cytokine pattern
early plays an important role in further promoting an
imbalance to the Th2 pattern. Colonization by S. aureus
not only switches the immune responses in inflammatory
skin lesions from a Th1 cytokine pattern to a Th2 pattern,
but also increases the duration of the Th2 immuno-
reaction pattern, leading to chronicity of the inflamma-
tion. Atopic dermatitis can appear to be chronic contact
dermatitis due to Df and the experimental contact derma-
titis in the present study presents an ideal model of the
inflammatory skin lesions with S. aureus colonization.
The number of S. aureus cells of the skin involved in
AD is usually less than 107 c.f.u./cm2, which represents a
colonization rather than an infection, meaning that there
would be no biological defense response such as infiltra-
tion of polymorphonuclear leukocytes phagocytozing the
microorganisms. Nevertheless, colonization of S. aureus
on AD skin lesions is considered to be one of the exacer-
bating factors in AD, even in the absence of clear infec-
tious signs.7,14,15 The number of S. aureus cells that were
inoculated in the present study is presumably consistent
with that seen in patients with AD. Even several hours
after inoculation, the number of S. aureus cells remained
at approximately 104 c.f.u./cm2 and, during this period,
the cytokine profile in the experimental lesions is still kept
in the Th2 pattern. Because the number of S. aureus
obtained from moderate AD lesions, but not from severe
lesions, is approximately 103 c.f.u./cm2, our present
findings are considered to be appropriate as a model of
AD  lesions with colonization of S. aureus. Colonizing
S. aureus can induce various cytokines, including tumor
necrosis factor-α from epidermal keratinocytes.15–17 Tumor
necrosis factor-α stimulates the eosinophils that have
infiltrated into the dermis to produce type 2 cytokines,
such as IL-4,18 and further stimulates dermal fibroblasts
to produce eotaxin,19 which promotes further infiltration
of Th2 cells20 into the lesion. Furthermore, IL-4 produced
by Th2 cells may activate Th2 cells. This activation series
may lead to the predominance of Th2 cells in inflamma-
tory lesions.
Fig. 4 Relative levels of cytokine mRNA expression at various
time points after inoculation with Staphylococcus aureus.
(a) Interleukin (IL)-4 mRNA is never detected in the 2,4,6-
trinitro-1-chlorobenzene (TNCB) control lesions; in contrast,
in the TNCB contact dermatitis with S.aureus lesions, the levels
of IL-4 mRNA are upregulated after inoculation. (), TNCB
control (IL-4); (), TNCB control (interferon (IFN)-γ);
(), TNCB + S. aureus (IL-4); (), TNCB + S. aureus (IFN-γ).
(b) In the Df with S. aureus lesions, IL-4 mRNA is upregulated
and the expression of IFN-γ mRNA is clearly suppressed for a
long time. (), Df control (IL-4); (), Df control (interferon
(IFN)-γ); (), Df + S. aureus (IL-4); (), Df + S. aureus (IFN-γ).
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Staphylococcal enterotoxin B is the most investigated
of the exotoxins produced by S. aureus and S. aureus cell
components in terms of its effects on human T lympho-
cytes. Campbell et al. reported that the production of
IFN-γ by peripheral blood mononuclear leukocytes
(PBML) from children with AD is significantly suppressed
after incubation with SEB, compared with that by PBML
from controls.21,22 Strickland et al. reported that super-
antigens increased the frequency of memory T cells
capable of migrating to activated AD lesions.23 The cell
wall elements of S. aureus, teicoic acid and peptide
glycan are also known to activate human T lymphocytes
to produce some cytokines.24,25 In the present study, we
used viable cells of S. aureus producing only SEB to
experimentally simulate human AD lesions colonized with
abundant S. aureus. Therefore, it is not clear which com-
ponent of S. aureus or SEB was responsible for modifying
the profile of the immune responses. However, consider-
ing recent in vitro and in situ studies together,21–25 as
shown in the present study, colonization with S. aureus
and its exotoxins can lead to imbalanced cytokine pro-
duction by allergen-specific T cells in the skin involved in
AD, never the preferential binding of S. aureus to skin
sites of established Th2-mediated inflammation.26
Further investigation is required to clarify the effect of
S. aureus on AD, especially in terms of the exotoxin level
produced by S. aureus to block the binding of S. aureus
to inflamed skin, leading to a new treatment for common
and refractory AD.
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